83 related articles for article (PubMed ID: 15022297)
1. Optimism and survival in lung carcinoma patients.
Schofield P; Ball D; Smith JG; Borland R; O'Brien P; Davis S; Olver I; Ryan G; Joseph D
Cancer; 2004 Mar; 100(6):1276-82. PubMed ID: 15022297
[TBL] [Abstract][Full Text] [Related]
2. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
3. Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.
Saito-Nakaya K; Nakaya N; Akechi T; Inagaki M; Asai M; Goto K; Nagai K; Nishiwaki Y; Tsugane S; Fukudo S; Uchitomi Y
Psychooncology; 2008 Sep; 17(9):869-76. PubMed ID: 18033697
[TBL] [Abstract][Full Text] [Related]
4. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
[TBL] [Abstract][Full Text] [Related]
5. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC
Cancer; 2007 Jan; 109(2):274-81. PubMed ID: 17154161
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
7. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer.
Akechi T; Okamura H; Okuyama T; Furukawa TA; Nishiwaki Y; Uchitomi Y
Psychooncology; 2009 Jan; 18(1):23-9. PubMed ID: 18484649
[TBL] [Abstract][Full Text] [Related]
10. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
11. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
Blumenschein GR; Khuri FR; von Pawel J; Gatzemeier U; Miller WH; Jotte RM; Le Treut J; Sun SL; Zhang JK; Dziewanowska ZE; Negro-Vilar A
J Clin Oncol; 2008 Apr; 26(11):1879-85. PubMed ID: 18398153
[TBL] [Abstract][Full Text] [Related]
14. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in pretreatment quality of life in a prospective lung cancer trial.
Siddiqui F; Kohl R; Swann S; Watkins-Bruner D; Movsas B
J Support Oncol; 2008 Jan; 6(1):33-9. PubMed ID: 18257399
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
17. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.
Sugimura H; Nichols FC; Yang P; Allen MS; Cassivi SD; Deschamps C; Williams BA; Pairolero PC
Ann Thorac Surg; 2007 Feb; 83(2):409-17; discussioin 417-8. PubMed ID: 17257962
[TBL] [Abstract][Full Text] [Related]
18. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status.
Stinchcombe TE; Choi J; Schell MJ; Mears A; Jones PE; Nachtsheim RV; Socinski MA
Lung Cancer; 2006 Feb; 51(2):237-43. PubMed ID: 16378657
[TBL] [Abstract][Full Text] [Related]
20. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
Mandrekar SJ; Schild SE; Hillman SL; Allen KL; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Chansky K; Kelly K; Adjei AA; Jett JR
Cancer; 2006 Aug; 107(4):781-92. PubMed ID: 16847887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]